NEW YORK, Nov. 12 – GPC Biotech of Munich said Monday its third quarter revenues rose 65 percent to 3.5 million euros ($3.1 million) from 2.1 million euros in the year ago period as a result of two new alliances.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.